vaccines

Showing 15 posts of 193 posts found.

Merck joins coalition for biosecurity vaccine plant

March 22, 2010
Manufacturing and Production, Research and Development biodefence, vaccines

Merck & Co will join in a new US project to create a vaccine research and manufacturing facility designed to …

immaticslogoJPG72dpi

Immatics vaccine trials to be conducted with Cancer Research UK

February 16, 2010
Research and Development immatics, vaccines

Cancer Research Technology, the development and commercial arm of Cancer Research UK, has reached an agreement to collaborate with German-based …

Pfizer to personalise brain tumour vaccine

February 8, 2010
Research and Development Pfizer, Qiagen, brain tumour, gliobastoma, vaccines

Pfizer is working with Dutch company Qiagen to develop a companion diagnostic kit for its immunotherapy vaccine for gliobastoma multiforme. …

Lancet retracts MMR research conclusions

February 3, 2010
Research and Development MMR, Sanofi, vaccines

The Lancet, the journal which originally published the controversial research linking the MMR vaccine to autism has issued a full …

Gates’ $10 billion vaccines pledge to cut child mortality

February 1, 2010
Research and Development, Sales and Marketing Gates Foundation, developing world, vaccines

Bill and Melinda Gates are to spend $10 billion over the next 10 years to help research, develop and deliver …

UK poised for shingles vaccination programme

February 1, 2010
shingles, vaccines

The government is to undertake what it calls “a rigorous procurement programme” to look for a suitable shingles vaccine. Possibilities …

Sanofi Pasteur collaborates on novel biologics

January 12, 2010
Research and Development KaloBios, Sanofi, Sanofi Pasteur, cystic fibrosis, infection, vaccines

Sanofi Aventis’ vaccines division has partnered with US biotech KaloBios to develop a number of novel biologic treatments. Sanofi Pasteur …

JGerberding_cdc_photo

Dr Julie Gerberding appointed to head up Merck Vaccines

January 6, 2010
Research and Development, Sales and Marketing Merck, appoinment, research and development, sales and marketing, vaccines

Merck & Co has put a US public health and infectious diseases expert in charge of its $5 billion global …

GSK signs needle-free vaccine alliance

December 16, 2009
Research and Development, Sales and Marketing GlaxoSmithKline, Intercell, patch, vaccines

GlaxoSmithKline has signed a deal with Intercell to see whether any of its vaccines could be made available in patch …

Sanofi invests in syringe production in France

December 16, 2009
Manufacturing and Production France, Sanofi-Aventis, vaccines

Sanofi-Aventis has doubled its capacity to manufacture syringe-delivered medicines with the opening of new production units at Le Trait, near …

GSK licences smoking vaccine candidate

November 30, 2009
Research and Development GSK, Nabi, smoking, vaccines

GlaxoSmithKline Biologicals has signed a licensing agreement for a nicotine vaccine candidate currently in the first of two phase III …

Novartis opens $1bn flu vaccine plant

November 25, 2009
Manufacturing and Production Novartis, US, vaccines

Novartis has opened a new $1 billion vaccine manufacturing plant that is the first to be set up as a …

GSK expands in China with vaccine joint venture

October 12, 2009
Sales and Marketing China, GSK, vaccines

GSK has joined with Chinese biotech Jiangsu Walvax to develop and manufacture paediatric vaccines for use in China.The pair will …

GSK agrees more government orders for H1N1 vaccine

October 7, 2009
Sales and Marketing GSK, h1n1, vaccines

GSK has agreed another 22 government orders for its adjuvanted swine-flu vaccine – an extra 149 million doses on top …

Cervarix not to blame for UK post-vaccination death

October 5, 2009
Sales and Marketing Cervarix, NHS, reg, vaccines

The death of a 14-year-old girl who died shortly after having received a cervical cancer vaccine was caused by an …

The Gateway to Local Adoption Series

Latest content